Forum Markets, Inc. (FRMM)
5.88
+0.22
(+3.89%)
USD |
NASDAQ |
Aug 28, 12:58
Forum Markets Cash from Operations (Quarterly) : -12.44M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -12.44M |
| March 31, 2026 | -20.45M |
| December 31, 2025 | -7.633M |
| September 30, 2025 | -16.43M |
| June 30, 2025 | -1.496M |
| March 31, 2025 | -0.887M |
| December 31, 2024 | -0.6248M |
| September 30, 2024 | -0.2399M |
| June 30, 2024 | 0.7272M |
| March 31, 2024 | -1.033M |
| December 31, 2023 | -2.16M |
| September 30, 2023 | -1.776M |
| June 30, 2023 | -3.117M |
| March 31, 2023 | -3.870M |
| December 31, 2022 | -2.927M |
| September 30, 2022 | -3.596M |
| June 30, 2022 | -3.532M |
| Date | Value |
|---|---|
| March 31, 2022 | -2.073M |
| December 31, 2021 | -5.028M |
| September 30, 2021 | -4.003M |
| June 30, 2021 | -4.011M |
| March 31, 2021 | -6.33M |
| December 31, 2020 | |
| September 30, 2020 | -0.054M |
| June 30, 2020 | -0.1926M |
| March 31, 2020 | -0.409M |
| December 31, 2019 | -0.292M |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | -0.2228M |
| September 30, 2018 | -0.2985M |
| June 30, 2018 | -0.1768M |
| March 31, 2018 | -0.2081M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Abeona Therapeutics, Inc. | -17.50M |
| Corcept Therapeutics, Inc. | 33.54M |
| ACADIA Pharmaceuticals, Inc. | 100.78M |
| Alnylam Pharmaceuticals, Inc. | 326.72M |
| Anika Therapeutics, Inc. | -0.684M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -17.79M |
| Cash from Financing (Quarterly) | -31.57M |
| Free Cash Flow | -318.80M |
| Free Cash Flow Per Share (Quarterly) | -0.729 |
| Free Cash Flow to Equity (Quarterly) | -11.29M |
| Free Cash Flow to Firm (Quarterly) | -12.20M |
| Free Cash Flow Yield | -310.5% |